INSTITUT BERGONIE
5Patents
5Active
5Granted
43Portfolio score
Filing activity: Apr 21, 2010 → Apr 19, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10189887B2 | Polypeptides and uses thereof for reducing CD95-mediated cell motility | Physics | 0 | Active |
| US9708666B2 | Prognostic molecular signature of sarcomas, and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11905253B2 | Compounds and pharmaceutical compositions for reducing CD95-mediated cell motility | Chemistry; Metallurgy | 0 | Active |
| US11052131B2 | Methods and pharmaceutical compositions for the treatment of kidney cancer | Chemistry; Metallurgy | 0 | Active |
| US10556941B2 | Polypeptides and uses thereof for reducing CD95-mediated cell motility | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.